Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
38°
Sunny
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Clarus Corp
(NQ:
CLAR
)
4.690
+0.060 (+1.30%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Clarus Corp
< Previous
1
2
3
4
Next >
Clarus (NASDAQ:CLAR) Misses Q3 Revenue Estimates
November 07, 2024
Outdoor lifestyle and equipment company Clarus (NASDAQ:CLAR) fell short of the market’s revenue expectations in Q3 CY2024, with sales falling 17.4% year on year to $67.12 million. The company’s...
Via
StockStory
What To Expect From Clarus’s (CLAR) Q3 Earnings
November 06, 2024
Outdoor lifestyle and equipment company Clarus (NASDAQ:CLAR) will be reporting earnings tomorrow after market hours. Here’s what to expect.
Via
StockStory
12 Consumer Discretionary Stocks Moving In Friday's Intraday Session
May 03, 2024
Via
Benzinga
CLAR Stock Earnings: Clarus Beats Revenue for Q1 2024
May 02, 2024
CLAR stock results show that Clarus beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
March 13, 2024
Via
Benzinga
Thursday Is Your Last Chance To Buy Clarus Before The Dividend Payout
March 12, 2024
Via
Benzinga
Clarus: Q4 Earnings Insights
March 07, 2024
Via
Benzinga
12 Consumer Discretionary Stocks Moving In Friday's Intraday Session
March 08, 2024
Via
Benzinga
CLAR Stock Earnings: Clarus Misses EPS, Misses Revenue for Q4 2023
March 07, 2024
CLAR stock results show that Clarus missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Few Aspects Of Clarus' Sales Of Precision Sport Segment Seems Odd, Says Analyst
January 02, 2024
Raymond James analyst Joseph Altobello reiterated a Market Perform rating on the shares of Clarus Corp (NASDAQ: CLAR).
Via
Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session
November 08, 2023
Via
Benzinga
Clarus: Q3 Earnings Insights
November 07, 2023
Via
Benzinga
Analyst Ratings for Clarus
September 18, 2023
Via
Benzinga
Clarus's Ex-Dividend Date Is Friday, Here's What You Need To Know
August 08, 2023
Via
Benzinga
Earnings Preview: Clarus
August 04, 2023
Via
Benzinga
Expert Ratings for Clarus
June 29, 2023
Via
Benzinga
Earnings Scheduled For March 7, 2024
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
Friday Is Your Last Chance To Buy Clarus Before The Dividend Payout
November 08, 2023
Via
Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session
September 06, 2023
Via
Benzinga
Fostering Confidence: Clarus Reliable Progress and Investor Expectations
August 25, 2023
Today, August 25, 2023, marks an important moment for investors of Clarus (NASDAQ:CLAR). The company will distribute a dividend payout of $0.03 per share, demonstrating an annualized dividend yield of...
Via
Benzinga
Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 14, 2023
Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration...
Via
Benzinga
What 4 Analyst Ratings Have To Say About Clarus
May 03, 2023
Via
Benzinga
Clarus: Dividend Insights
May 02, 2023
Via
Benzinga
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
August 07, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2023
June 29, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2023
May 03, 2023
Via
Benzinga
Clarus Earnings Preview
April 28, 2023
Via
Benzinga
Clarus's Return On Capital Employed Insights
March 02, 2023
Via
Benzinga
Earnings Scheduled For May 1, 2023
May 01, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.
Via
Benzinga
10 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
April 05, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.